In GBM, the most common genetic lesions, including p53, PTEN, and P16 (also known as p16INK4A, cyclin-dependent kinase inhibitor 2A), have been reported to regulate the DNA damage response [10]. The gene discussed is CDKN2A; the disease is glioblastoma.